Ehlers-danlos Syndrome, Musculocontractural Type, 2; Edsmc2

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

The musculocontractural type of Ehlers-Danlos syndrome is characterized by progressive multisystem fragility-related manifestations, including joint dislocations and deformities; skin hyperextensibility, bruisability, and fragility, with recurrent large subcutaneous hematomas; cardiac valvular, respiratory, gastrointestinal, and ophthalmologic complications; and myopathy, featuring muscle hypoplasia, muscle weakness, and an abnormal muscle fiber pattern in histology in adulthood, resulting in gross motor developmental delay (summary by Muller et al., 2013).For a discussion of genetic heterogeneity of the musculocontractural type of Ehlers-Danlos syndrome, see EDSMC1 (OMIM ).

Genes related to Ehlers-danlos Syndrome, Musculocontractural Type, 2; Edsmc2

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Ehlers-danlos Syndrome, Musculocontractural Type, 2; Edsmc2

Global developmental delay
Hypertelorism
Muscle weakness
Abnormal facial shape
Pain
High palate
Motor delay
Downslanted palpebral fissures
Frontal bossing
Talipes equinovarus

And another 32 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Ehlers-danlos Syndrome, Musculocontractural Type, 2; Edsmc2 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
DSE. By Institute for Human Genetics University Clinic Freiburg (Germany). DSE Specificity 100 % Genes 100 %
Connective Tissue Disorders Panel. By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center (United States). BGN, SKI, TGFB2, TGFB3, TGFBR1, TGFBR2, MED12, TNXB, C1R, C1S, ACTA2, ADAMTS10, SLC2A10, ADAMTSL2, CBS, TAB2, B3GALT6, ATP6V0A2, FKBP14, RIN2 , (...) View the complete list with 45 more genes Panel complete gene list BGN, SKI, TGFB2, TGFB3, TGFBR1, TGFBR2, MED12, TNXB, C1R, C1S, ACTA2, ADAMTS10, SLC2A10, ADAMTSL2, CBS, TAB2, B3GALT6, ATP6V0A2, FKBP14, RIN2, SLC39A13, DSE, ADAMTS2, COL11A1, COL11A2, COL1A2, COL3A1, COL5A1, COL5A2, COL9A1, COL9A2, COL9A3, ZNF469, CHST14, GORAB, FLCN, MFAP5, EFEMP2, ELN, FBLN5, FBN1, FBN2, FLNA, FOXE3, ABCC6, LOX, LTBP4, SMAD2, SMAD3, SMAD4, SMAD6, MYH11, MYLK, NOTCH1, NOTCH2, ATP7A, PKD1, PKD2, PLOD1, B4GALT7, PRDM5, PRKG1, PTDSS1, PYCR1, ALDH18A1 Specificity 2 % Genes 100 %
Ehlers-Danlos Syndrome Panel. By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center (United States). TNXB, C1R, C1S, B3GALT6, FKBP14, SLC39A13, DSE, ADAMTS2, COL1A2, COL3A1, COL5A1, COL5A2, CHST14, FLNA, ATP7A, PLOD1, B4GALT7 Specificity 6 % Genes 100 %
Ehlers-Danlos Syndromes Sequencing Panel with CNV Detection. By PreventionGenetics PreventionGenetics (United States). SPARC, TGFBR1, TGFBR2, TNFRSF1A, TNXB, C1R, C1S, LZTS1, ADAMTSL2, B3GALT6, ATP6V0A2, FKBP14, RIN2, CHST3, SLC39A13, DSE, ADAMTS2, COL12A1, COL1A2, COL3A1 , (...) View the complete list with 24 more genes Panel complete gene list SPARC, TGFBR1, TGFBR2, TNFRSF1A, TNXB, C1R, C1S, LZTS1, ADAMTSL2, B3GALT6, ATP6V0A2, FKBP14, RIN2, CHST3, SLC39A13, DSE, ADAMTS2, COL12A1, COL1A2, COL3A1, COL5A1, COL5A2, ZNF469, CHST14, GORAB, AEBP1, EFEMP2, ELN, FBLN5, FLNA, FLNB, GGCX, SMAD3, ATP6V1A, ATP6V1E1, ATP6AP1, ATP7A, PLOD1, PLP1, B3GAT3, B4GALT7, PRDM5, PYCR1, ALDH18A1 Specificity 3 % Genes 100 %
Ehlers-Danlos syndrome Deletion / Duplication panel - Recessive. By Connective Tissue Gene Tests (United States). B3GALT6, FKBP14, SLC39A13, DSE, ADAMTS2, COL12A1, ZNF469, CHST14, ATP7A, PLOD1, B4GALT7, PRDM5 Specificity 9 % Genes 100 %
Ehlers-Danlos syndrome NGS panel - Dominant & Recessive. By Connective Tissue Gene Tests (United States). C1R, C1S, B3GALT6, FKBP14, SLC39A13, DSE, ADAMTS2, COL12A1, COL1A2, COL3A1, COL5A1, COL5A2, ZNF469, CHST14, FLNA, ATP7A, PLOD1, B4GALT7, PRDM5 Specificity 6 % Genes 100 %
Ehlers-Danlos syndrome Comprehensive panel - Recessive. By Connective Tissue Gene Tests (United States). B3GALT6, FKBP14, SLC39A13, DSE, ADAMTS2, COL12A1, ZNF469, CHST14, ATP7A, PLOD1, B4GALT7, PRDM5 Specificity 9 % Genes 100 %
Ehlers-Danlos syndrome NGS panel - Recessive. By Connective Tissue Gene Tests (United States). B3GALT6, FKBP14, SLC39A13, DSE, ADAMTS2, COL12A1, ZNF469, CHST14, ATP7A, PLOD1, B4GALT7, PRDM5 Specificity 9 % Genes 100 %

You can get up to 21 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOFIBROMATOSIS, INFANTILE, 2; IMF2 NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D